Holden C A, Sanderson A R, MacDonald D M
J Am Acad Dermatol. 1983 Dec;9(6):867-71. doi: 10.1016/s0190-9622(83)70200-8.
Four highly sensitive monoclonal antibodies were assessed for their use in an immunoperoxidase technic on cutaneous sections. Three, B2, C23, and 2A1, were found to discriminate basal cell carcinomas (BCCs) from benign proliferative disorders of skin, and 2A1, a monoclonal antibody against the heavy chain component of class 1 human leukocyte antigens (HLA) for the first time directly demonstrated the absence of this structure from the malignant cell membrane. However, the deeper portions of hair follicles were also found to be unlabeled, and further study of benign follicular tumors which may histologically mimic basal cell carcinomas is suggested.
对四种高灵敏度单克隆抗体进行了评估,以确定它们在皮肤切片免疫过氧化物酶技术中的应用。发现其中三种抗体,即B2、C23和2A1,可将基底细胞癌(BCC)与皮肤良性增殖性疾病区分开来,而2A1是一种针对人类白细胞抗原(HLA)1类重链成分的单克隆抗体,首次直接证明恶性细胞膜上不存在这种结构。然而,还发现毛囊较深部分也未被标记,因此建议对可能在组织学上模仿基底细胞癌的良性毛囊肿瘤进行进一步研究。